0 CHECKOUT

PRODUCT FILTERS

REGION

72
9
8
8
3

COUNTRY

8
1
1

PRICE

7
11
38
124

PUBLISHED

0
4
20
124

PRODUCT TYPE

119
4
1

Breast Cancer

Over a million women worldwide are diagnosed with breast cancer annually. Alongside surgery, radiotherapy and immunotherapy, pharmaceutical products (including hormonal therapy and chemotherapy) are in the frontline against this terrible disease. Market reports in this section enable buyers to read up on the latest breast cancer drug pipelines and R&D strategies, as well as the medical and commercial activities of major players and niche operators such Abraxis Bioscience, Aeterna Zentaris, Agendia BV, Aphton Corp, Array BioPharma, AstraZeneca Plc, Bristol Myers Squibb, Dendreon Corporation, Eli Lilly, Genentech, Genta, Novartis AG, Pfizer, Roche Group, Sanofi-Aventis, Schering AG, Therion Biologics, and ViRexx Medical. Also included are cutting edge academic journals and various expert textbooks for medical professionals involved in breast cancer treatment. Show Less Read more

124 Products

Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

The report on breast cancer therapeutics: pipeline analysis market studies the future market of breast cancer drugs on the basis of the molecules which are currently under pipeline. Breast cancer usually...

Published:  August 2015
Price:  From

Global HER-2 Positive Breast Cancer Market 2015-2019

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer...

Published:  March 2015
Price:  From

HER-2 Positive Breast Cancer Market in the US 2015-2019

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer...

Published:  March 2015
Price:  From

Global Breast Cancer Market 2014-2018

About Breast Cancer Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically,...

Published:  June 2014
Price:  From

Mammography World Markets

Breast cancer is the most common type of cancer in women, affecting one in eight during their lives Mammography is the most valuable method for detecting potentially cancerous anomalies in the breast...

Published:  December 2012
Price:  From

Breast Cancer Therapies Markets

Breast cancer therapies are entering a new era as game-changers emerge for each of the major breast cancer patient populations New market entrants must possess drug profiles and a savvy clinical development...

Published:  November 2012
Price:  From

Global Breast Cancer Market Report: 2015 Edition

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location....

Published:  August 2015
Price:  From

Breast Cancer Pipeline Highlights - 2015

The latest report Breast Cancer Pipeline Highlights – 2015 Update, provides most up-to-date information on key pipeline molecules in the global Breast Cancer market. It covers emerging therapies for...

Published:  July 2015
Price:  From

Breast Cancer Drug Pipeline Update 2015

Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic...

Published:  June 2015
Price:  From

A Competitive Analysis of the Global Breast Cancer Therapeutics Market

The study assesses marketed and investigational products and combination regimens for the global breast cancer therapeutics market. Segmentation by drug class is provided, along with supporting information,...

Published:  March 2015
Price:  From

Breast Cancer Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 567 targeted molecular therapies known to affect more than 256 specific intracellular signaling pathways...

Published:  January 2015
Price:  From

Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Breast Cancer patient population study in a new report ‘Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

Published:  January 2015
Price:  From

Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Herceptin (HER2-Positive Breast Cancer)...

Published:  September 2014
Price:  From

Neratinib (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Neratinib (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Neratinib (HER2-Positive Breast Cancer)...

Published:  September 2014
Price:  From

Tykerb (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Tykerb (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Tykerb (HER2-Positive Breast Cancer) - Forecast...

Published:  September 2014
Price:  From

Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Perjeta (HER2-Positive Breast Cancer) -...

Published:  September 2014
Price:  From

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer...

Published:  September 2014
Price:  From

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer...

Published:  September 2014
Price:  From

Kadcyla (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023

Kadcyla (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary The publisher has released its new PharmaPoint Drug Evaluation report, “Kadcyla (HER2-Positive Breast Cancer) -...

Published:  September 2014
Price:  From

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer...

Published:  September 2014
Price:  From
Loading Indicator

Our Clients